KALV – kalvista pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
KalVista Pharmaceuticals Presents New Data Highlighting High Patient Satisfaction and Evolving Treatment Trends with EKTERLY® (sebetralstat) [Yahoo! Finance]
KalVista Pharmaceuticals Presents New Data Highlighting High Patient Satisfaction and Evolving Treatment Trends with EKTERLY® (sebetralstat)
KalVista Pharmaceuticals to Present at Upcoming Investor Conferences
KalVista Pharmaceuticals Announces Inclusion of EKTERLY® (sebetralstat) as a First-Line Therapy for Adolescents 12 and Older in International Pediatric HAE Guideline
Form 4 KalVista Pharmaceuticals For: Feb 21 Filed by: Audhya Paul K.
Form 4 KalVista Pharmaceuticals For: Feb 21 Filed by: Palleiko Benjamin L
Form 4 KalVista Pharmaceuticals For: Feb 21 Filed by: Yea Christopher
Form 4 KalVista Pharmaceuticals For: Feb 21 Filed by: Sweeny Nicole
Form 4 KalVista Pharmaceuticals For: Feb 21 Filed by: Piekos Brian
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.